Search bioRxiv⌕ Search

Biology subjects

Kamal, I. M.

Publications and source records attributed to Kamal, I. M..

2 recordsLinked to original sources

Computational insights into the interaction between Topoisomerase I and Rpc82 subunit of RNA Polymerase III in Saccharomyces cereviseae

The process of DNA transcription leads to the generation of torsional stress, which must be resolved for smooth progression of the transcription machinery. In Saccharomyces cerevisiae, DNA topoisomerase I (Top1), a type IB topoisomerase, plays a critical role in relaxing supercoils and mitigating the topological strain associated with transcription. While several proteins from the transcription machinery have been reported to interact with yeast Top1, detailed characterization and functional relevance of these interactions have remained underexplored. This gap is partly due to the absence of a complete three-dimensional structure of the full-length enzyme, which hinders structure-based computational analyses of its interactome. In this study, we present a template-based model of full-length yeast Top1. Leveraging this model, we investigated its molecular interaction with Rpc82, a key subunit of RNA polymerase III enzyme, responsible for transcribing small non-coding RNAs such as tRNAs and 5S rRNA. Through molecular docking and molecular dynamics simulations, critical residues at the Top1-Rpc82 interface were identified that likely mediate their interaction. Our findings provide new insights into the structural basis of Top1s association with RNA polymerase III and its potential role in regulating Pol III-mediated transcription. The Top1 model developed here offers a valuable framework for future in silico studies aimed at elucidating the broader interactome and regulatory mechanisms of this essential enzyme.

bioinformatics↗

Epoxyazadiradione ameliorates Parkinson's disease by upregulating heat shock factor 1 and protein degradation pathways in mice.

Parkinsons disease (PD) is a major debilitating health concern for millions of the elderly population all over the world. This progressive neurodegenerative disorder also poses a severe mental and financial burden to caregivers and society. Despite a major thrust on research for therapy development, no significant progress has been made; only temporary management options are currently available. To this end, we have reported azadiradione (AZD), a triterpenoid that we isolated from neem seed extract using a cell-based assay. AZD showed high efficacy in ameliorating protein aggregation-induced pathology and symptoms in fruit flies and mice. Current evidence suggests that AZD functions through activating the transcriptional function of heat shock factor 1 (HSF1), a master regulator of protein quality control pathways, without modulating the cellular redox balance. To better understand the pharmacophore of AZD, a triterpenoid in its observed function, we have analysed various structural derivatives, focusing on their HSF1-activating function in vitro and their efficacies in ameliorating protein aggregation-induced toxicities in cell and mouse models. Our analyses, based on real-time PCR, immunoblots, fluorescent anisotropy, and a mouse model of MPTP-induced PD, highlighted Epoxy-azadiradione (Epoxy) as being as efficient as AZD in in vivo functional tests, albeit activating the promoter binding activity of HSF1 with at least two-fold higher efficacy in vitro. Notably, similar to AZD, Epoxy did not induce cellular redox imbalance. We also incorporated molecular docking analyses involving the published crystal structure of the DNA-binding domain of HSF1 bound to its DNA recognition element to study molecular dynamics-based energy estimation. The analysis revealed a higher energy stability of the epoxy-bound complexes, as indicated by a significant decrease in binding free energy ({Delta}G) estimated from an ensemble of intermediate docked complex structures.

pharmacology and toxicology↗